Navigation Links
Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
Date:5/21/2012

MALVERN, Pa., May 21, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) is raising its full year 2012 revenue guidance to a range of $293 to $315 million and is reducing its guidance for net loss to a range of $5 to $10 million.  The Company will be holding a conference call today, May 21, 2012, at 10:00 am ET to discuss the agreement for the Testim® U.S. co-promotion with GlaxoSmithKline LLC, the U.S. subsidiary of GlaxoSmithKline plc (LSE: GSK).

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO)

The Company's previous and revised full year 2012 financial guidance is ($ millions):  PreviousRevisedTotal Revenue$283 - $305$293 - $315Global Testim Revenues$215 - $225$225 - $235Xiaflex:U.S. Revenues$55 - $65$55 - $65  Ex-U.S. / Def. Rev$13 - $15$13 - $15Total XIALEX$68 - $80$68 - $80R&D Expense$55 - $65$55 - $65S G & A Expense$180 - $190$180 - $190Net Income (Loss)$(5) - $(15)$(5) - $(10) "As a result of this morning's announcement concerning the Testim U.S. co-promotion agreement, we are increasing Testim revenue guidance and trimming net loss guidance for 2012,"  said Jim Fickenscher, Chief Financial Officer of Auxilium.  "While we have not changed our previously stated guidance for Selling, General & Administrative expense, it is likely that we will be near the top end of the range."

Conference Call
The presentation slides to be used during the call will be available on the "For Investors" section of the Company's web site under the "Presentations" tab at 10:00 a.m. ET.  A question and answer session will follow the presentation.  The conference call and the presentation slides will be simultaneously web cast on the "For Investors" section of the Company's web site under the "Events" tab
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015 BiondVax ... preliminary results from its BVX-006 Phase II clinical trial ... In this trial, M-001 was injected intramuscularly to volunteers ... an administration of the 2014/15 season trivalent influenza vaccine ... safe and well tolerated and induced humoral immune responses, ...
(Date:6/29/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Russell 1000 Index, effective June 26, 2015. The Russell ... of the U.S. equity universe. It is a subset ... of the largest securities based on a combination of ... "We are pleased to be added to this important ...
(Date:6/29/2015)... SAN JOSE, Calif. , June 29, 2015 ... its expert medical workstation lineup. The high-powered, multi-functional ... th generation Intel® Haswell Core ... processor. Both provide significant data processing and computing ... visual performance, making the unit well suited for ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... health,officials will honor residents of Framingham, Mass., Nov. 29, ... the thousands of,individuals who have participated in the landmark ... keynote speaker at an event in,Framingham honoring the participants, ... data from the study. This represents the first,time a ...
... Nov. 20 PAREXEL International,Corporation (Nasdaq: ... bio/pharmaceutical services,organization, has appointed Dr. Victor ... Pharmacoepidemiology within the Company,s Clinical Research,Services ... clients in,the design and conduct of ...
Cached Medicine Technology:Top Washington Health Officials to Honor Framingham Heart Study Participants 2PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 2PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 3PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 4
(Date:6/30/2015)... ... June 30, 2015 , ... Americans report feeling more stressed than ever ... mornings, which puts stressed out people right over the edge. , Almost half ... sleep deprivation every night. Sleeping pills now lead the list of the most prescribed ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... “It is ... founder of SunGrubbies.com. “We are particularly interested in getting the word out to ... years to surface. We are extremely pleased with our new video which ...
(Date:6/29/2015)... ... 30, 2015 , ... Aespala Medspa and Plastic Surgery is proud to introduce ... , Dr. Dreyfuss received his medical degree from Emory University in Atlanta before ... Plastic Surgery Fellowship at the University of Chicago. He has taught and practiced medicine ...
(Date:6/29/2015)... , ... June 30, 2015 , ... ... set of revised Guidelines for Neuro Musculoskeletal Thermography and Sympathetic Skin Response Studies.* ... Guidelines that were first published in 2006, are intended to aid physicians and ...
(Date:6/29/2015)... ... June 29, 2015 , ... Healthpointe, one ... Dr. John A. Mitamura, MD., PhD into their world-class multidisciplinary team of physicians ... Long Beach , Irwindale and La Tijera-Los Angeles. , Orthopedic surgeons ...
Breaking Medicine News(10 mins):Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 3Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3
... projects require care and caution , , SUNDAY, March 29 (HealthDay ... yard work -- but if they,re not careful, it might ... with ladders, gardening tools and lawn mowers alone cause hundreds ... according to the U.S. Consumer Product Safety Commission. Many of ...
... produce better outcomes, study finds, , , SUNDAY, March 29 (HealthDay ... hoped would improve symptoms in people with heart failure ... , , The hope was that by isolating the damaged ... heart that pumps blood to the body -- people would ...
... for individuals who want to earn substantial income through sale of products ... Health has created a risk-free, hassle-free affiliate system with tremendous financial upsides. ... affiliate program. , ... New York (PRWEB) March 29, 2009 -- Looking ...
... rose after a defeat, and dropped after a victory , , ... team lose in the Super Bowl could actually end your ... is that a victory might do just the opposite, the ... College of Cardiology annual meeting, in Orlando, Fla. , To ...
... drug warfarin for many patients, researchers say, , , SATURDAY, ... soon replace the anti-clotting drug warfarin as the first ... a new study suggests. , People with atrial fibrillation ... noted, and typically need to take warfarin for the ...
... gestational age, being male did have a correlation , , ... affect the extent of head flattening in infants, U.S. ... severity of asymmetrical head shape, known as deformational plagiocephaly ... condition. , Since the early 1990s, parents have been ...
Cached Medicine News:Health News:Tips to Avoid Spring Cleaning Mishaps 2Health News:New Surgery for Heart Failure Proves Ineffective 2Health News:New Surgery for Heart Failure Proves Ineffective 3Health News:ZEO Health's New Program Offers Answer for Those Looking for Income 2Health News:Super Bowl Loss Can 'Kill' Some Fans 2Health News:New Device Treats Common Heart Rhythm Disorder 2Health News:New Device Treats Common Heart Rhythm Disorder 3Health News:Baby's Sleep Position May Not Affect Severity of Head Flattening 2
... sophisticated Aumated Immunoassay Analyzer that fits in any ... 16 X 16 X 21 inches and weighs ... for physician office laboratories, work stations for small ... well as a dedicated system for specialty testing. ...
... ECi brings true automation and continuous ... Highly sensitive assays for thyroid, anemia, ... metabolism testing are currently available, with ... Vitros ECi can simultaneously process 60 ...
... the Therapeutic Drug Monitoring Market in 1981 ... in use today, this system uses technology ... measure serum drug concentration in a patient. ... different diseases, often exhibit a narrow therapeutic ...
Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
Medicine Products: